REFERENCE
Shiroiwa T, Fukuda T, Shimozuma K, Ohashi Y, Tsutani K.Cost-effectiveness analysis of capecitabine compared with bolus 5-fluorouracil/l-leucovorin for the adjuvant treatment of colon cancer in Japan. PharmacoEconomics 27: 597-608, No. 7, 2009
Rights and permissions
About this article
Cite this article
Capecitabine dominant over fluorouracil/levofolinate in Japan. Pharmacoecon. Outcomes News 586, 6 (2009). https://doi.org/10.2165/00151234-200905860-00014
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200905860-00014